跳至主要内容
临床试验/NL-OMON47762
NL-OMON47762
已完成
不适用

Effects of light on emotional processing - Light and emotional processing

VU Medisch Centrum, Amsterdam UMC0 个研究点目标入组 60 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
VU Medisch Centrum, Amsterdam UMC
入组人数
60
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Observational non invasive

研究者

发起方
VU Medisch Centrum, Amsterdam UMC

入排标准

入选标准

  • Depression:
  • \- Age \> 40 years
  • \- Significant symptoms of depression (score \> 13 on the Inventory of Depressive Symptomatology (IDS\-SR))40
  • \- Symptomatic on the depression part of the Composite International Diagnostic Interview \* Short Form (CIDI\-SF)41
  • \- Willingness and ability to give written informed consent and willingness and ability to understand, to participate and to comply with the study requirements.;PD:
  • \- Age \> 40 years
  • \- Idiopathic PD, as diagnosed by the UK Brain Bank Criteria
  • \- Mild PD stage 1\-3, based on Hoehn \& Yahr scale
  • \- Willingness and ability to give written informed consent and willingness and ability to understand, to participate and to comply with the study requirements
  • \- MMSE 24;Control:

排除标准

  • \- Early onset PD (\< 40 years)
  • \- Treatment with continuous apomorphine infusion, intestinal duodopa therapy or deep brain stimulation (DBS);\- PD patients with excessive tremor.;Control:
  • \- Current or past psychiatric diagnosis
  • \- Significant symptoms of depression (score \> 13 on the IDS\-SR)
  • \- Symptomatic on the CIDI\-SF.;All groups
  • \- Current diagnosis of bipolar disorder, psychotic disorder, alcohol or substance dependence, or any cognitive disorder
  • \- Neurological disease (other than PD for the PD group) stroke or major head trauma, current or in history
  • \- MRI contraindications such as metal implants, claustrophobia, left\-handedness, pregnancy
  • \- Self\-reported inability or unease to cease smoking for 24 hours prior to testing
  • \- Current treatment with tricyclic antidepressant or antipsychotic medication

结局指标

主要结局

未指定

相似试验